Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma

NCT03294083

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Site 2644 University of California, Irvine Irvine, California, United States

Site 2641 University of Miami Miami, Florida, United States

Site 2643 Washington University St Louis, Missouri, United States

Site 2642 Billings Clinic Billings, Montana, United States

View all 21 locations

View Trial Details

Completed

Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective Study

NCT07657299

Conditions: Bladder Cancer, Bladder Cancer Recurrence, Carcinoma, +19 more
Locations: Faculty of medicine, Ain Shams University Cairo, Abbasia, Egypt

View Trial Details

Completed

A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

NCT05708950

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +76 more
Locations: UCLA Health (Santa Monica Cancer Care) Santa Monica, California, United States

Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States

Sarah Cannon Research Institute at Florida Cancer Specialists Sarasota, Florida, United States

University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)

NCT04941768

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Imelda Ziekenhuis Bonheiden, Belgium

AZ KLINA Brasschaat, Belgium

AZ Sint-Jan Bruges, Belgium

Klinikum St. Marien Amberg Amberg, Germany

View all 61 locations

View Trial Details

Completed

Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer

NCT03455452

Conditions: Adenocarcinoma, Adenocarcinoma Of Kidney, Adenocarcinoma, Renal Cell, +19 more
Locations: Local Institution - 0001 Paris, France

View Trial Details

Completed

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

NCT03258593

Conditions: Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +12 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).

NCT05858749

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Pfizer Headquarters New York, United States

View Trial Details

Completed

TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative

NCT03630536

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Completed

Urinary Markers by SpectrosCopy: Diagnostic Aid in oncologY - Application to Urological Cancers

NCT06087016

Conditions: Disease, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations: Damien JOLLY Reims, France

View Trial Details

Completed

A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)

NCT04495257

Conditions: Adenocarcinoma, Advanced Melanoma, Carcinoma, +15 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

Yale New Haven Hospital New Haven, Connecticut, United States

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions